Market Research Logo

Crohn's Disease Treatment Market - Global Forecast to 2026

Crohn's Disease Treatment Market - Global Forecast to 2026

Report Description
Crohn’s disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small intestine to the colon of the large intestine. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, reduced appetite, fever, and frequent diarrhea. Rectal bleeding is encountered in few cases due to fissures from inflammation at anal canal. Factors responsible for causing Crohn’s disease include hereditary genes, autoimmune reaction that causes inflammatory condition, and environmental factors such as bacteria and virus. The disease majorly affects people falling between age group of 15-35 years and occurs in moth males and females.
Market Dynamics
The North America and Europe regions have high incidence of Crohn’s disease, which is expected to drive the growth of market. According to the journal of Gastroenterology’s on Inflammatory Bowel Disease (IBD) in 2017, around 1.6 million patient in the U.S were suffering from of IBD, out of which considerable section belongs to Crohn’s disease. Additionally, fast-track drug approval application of FDA pertaining to treatments for Crohn’s disease is also expected to foster the market in the forecast years. The pipeline drugs offering innovative treatment solutions expecting to receive marketing approvals are anticipated to propel the market growth. For instance, launch of interleukin (IL) inhibitor and anti-integrin therapy for Crohn’s disease, risankizumab, is in the Phase III clinical trials of FDA developed by AbbVie and is expected to complete its trials by January 2022. However, lack of awareness regarding available treatment options is expected to act as hindrance in the market growth.
Key features of the study:

  • This report provides in-depth analysis of Crohn’s disease treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global Crohn’s disease treatment market based on the following parameters – company overview, product description, key highlights, financial performance and strategies
  • Key companies covered as a part of this study includes AbbVie Inc., Janssen Biotech, Inc., Allergan Inc., Bayer AG, Bristol-Myers Squibb, Pfizer, Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Company, GlaxoSmithKline plc, Novartis International AG, Sanofi, and Takeda Pharmaceutical Company Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, market expansion, and marketing tactics
  • The global Crohn’s disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Crohn’s disease treatment market
Detailed Segmentation:
  • Global Crohn’s Disease Treatment Market, By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • Global Crohn’s Disease Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • Global Crohn’s Disease Treatment Market, By Region:
  • North America
  • By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Type:
  • Antibiotics
  • Amino Salicylates
  • Corticosteroids
  • Immunomodulators
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • AbbVie, Inc. *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Janssen Biotech, Inc.
  • Allergen, Inc.
  • Bayer AG
  • Bristol Myers Squibb
  • Boehringer Ingelheim GmbH
  • Pfizer, Inc.
  • F-Hoffmann La-Roche
  • Eli Lily and Company
  • GlaxoSmithKline Plc
  • Novartis AG
  • Sanofi
  • Takeda Pharmaceutical Company Limited
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Key Highlights
Market Trends
PORTER’s Five Forces Analysis
Epidemiology
4. Global Crohn’s Disease Treatment Market, By Drug Type, 2018-2026, (US$ Million)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Amino Salicylates
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Immunomodulators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Crohn’s Disease Treatment Market, By Distribution Channel, 2018-2026, (US$ Million)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
e-Commerce
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Crohn’s Disease Treatment Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2017 and 2026 (%)
Y-o-Y Growth Analysis, Region, 2017 – 2026
North America
Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
Market Size and Forecast, By Country, 2016-2026, (US$ Million)
U.S.
Canada
Latin America
Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
Market Size and Forecast, By Country, 2016-2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
Market Size and Forecast, By Country, 2016-2026, (US$ Million)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
Market Size and Forecast, By Country, 2016-2026, (US$ Million)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
Market Size and Forecast, By Country, 2016-2026, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Drug Type, 2016-2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
Market Size and Forecast, By Country, 2016-2026, (US$ Million)
South Africa
Central Africa
North Africa
7. Competitive Landscape
Heat Map Analysis
Company Profiles
AbbVie, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Janssen Biotech, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Allergen, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Bayer AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Bristol Myers Squibb
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Boehringer Ingelheim GmbH
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
F-Hoffmann La Roche
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Eli Lily and Company
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Novartis AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Takeda Pharmaceutical Company Limited
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
8. Section
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 38 figures on "Crohn’s Disease Treatment Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report